TheEvidence
Science based writing on longevity, cancer, nutrition, supplements, hormones and preventive care. Written by our doctors, researchers and coaches. Every article carries a named clinician and the date it was last reviewed.
HRT: what it is, and who it actually suits
HRT is not one treatment. The hormone, the dose, the route and the timing all change who it suits.
Fasting insulin: the marker that moves years before glucose
Glucose tells you the result. Fasting insulin tells you what it cost to get there, and it moves years earlier.
Tumour markers: what they can and cannot tell you
Tumour markers are blood proteins, not cancer tests on their own. A raised result raises a question, not an answer.
Lp(a): the inherited risk you test once
Lp(a) is set by your genes and barely changes through life. Testing it once tells you something cholesterol cannot.
ApoB: the number that predicts heart risk
ApoB counts the particles that drive heart disease. It can tell you more about your risk than cholesterol alone.
Fatty liver in Singapore: what the scan and the bloods show
Fatty liver affects roughly one in three adults. Most have no symptoms, and in Asian populations it appears at weights that look...
The Evidence Report
Once a year, every January, we publish what our own patient data shows. Prevalence across the markers we test, what changed for members who retested, and what we got wrong. The first edition lands January 2027.
One email, every other week.
What we published, what we read, and the one thing worth changing. Nothing to buy.
